Article: Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.
2006 Volume 210, Issue 3, Page(s) 288–297
Abstract: ... patients who died of SARS. SARS-CoV S protein and its RNA were only detected in ACE2+ cells in the lungs ... in the uninfected cells. These results suggest that cells infected by SARS-CoV produce elevated levels of PICs ... in vivo in humans. High levels of PICs were expressed in the SARS-CoV-infected ACE2+ cells, but not ...
| Abstract | The authors have previously shown that acute lung injury (ALI) produces a wide spectrum of pathological processes in patients who die of severe acute respiratory syndrome (SARS) and that the SARS coronavirus (SARS-CoV) nucleoprotein is detectable in the lungs, and other organs and tissues, in these patients. In the present study, immunohistochemistry (IHC) and in situ hybridization (ISH) assays were used to analyse the expression of angiotensin-converting enzyme 2 (ACE2), SARS-CoV spike (S) protein, and some pro-inflammatory cytokines (PICs) including MCP-1, TGF-beta1, TNF-alpha, IL-1beta, and IL-6 in autopsy tissues from four patients who died of SARS. SARS-CoV S protein and its RNA were only detected in ACE2+ cells in the lungs and other organs, indicating that ACE2-expressing cells are the primary targets for SARS-CoV infection in vivo in humans. High levels of PICs were expressed in the SARS-CoV-infected ACE2+ cells, but not in the uninfected cells. These results suggest that cells infected by SARS-CoV produce elevated levels of PICs which may cause immuno-mediated damage to the lungs and other organs, resulting in ALI and, subsequently, multi-organ dysfunction. Therefore application of PIC antagonists may reduce the severity and mortality of SARS. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Acute Disease ; Angiotensin-Converting Enzyme 2 ; Chemokine CCL2/analysis ; Cytokines/analysis ; Humans ; Immunohistochemistry/methods ; In Situ Hybridization/methods ; Interleukin-1beta/analysis ; Interleukin-6/analysis ; Lung/chemistry ; Lung/pathology ; Male ; Models, Biological ; Peptidyl-Dipeptidase A/analysis ; Severe Acute Respiratory Syndrome/immunology ; Severe Acute Respiratory Syndrome/metabolism ; Severe Acute Respiratory Syndrome/pathology ; Transforming Growth Factor beta1/analysis ; Tumor Necrosis Factor-alpha/analysis ; Viral Proteins/analysis | |||||
| Chemical Substances | CCL2 protein, human ; Chemokine CCL2 ; Cytokines ; Interleukin-1beta ; Interleukin-6 ; Transforming Growth Factor beta1 ; Tumor Necrosis Factor-alpha ; Viral Proteins ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) | |||||
| Keywords | covid19 | |||||
| Language | English | |||||
| Publishing date | 2006-09-22 | |||||
| Publishing country | England | |||||
| Document type | Journal Article ; Research Support, Non-U.S. Gov't | |||||
| ZDB-ID | 3119-7 | |||||
| ISSN | 1096-9896 ; 0022-3417 | |||||
| ISSN (online) | 1096-9896 | |||||
| ISSN | 0022-3417 | |||||
| DOI | 10.1002/path.2067 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ud II Zs.12: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.